Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL3096799

Cc1cccc(N2CCN([C@@H]3CNC[C@H]3O)CC2)n1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR3E A5X5Y0 1/20 0.43
HTR3B O95264 1/20 0.43
HTR3A P46098 1/20 0.43
HTR3D Q70Z44 1/20 0.43
HTR3C Q8WXA8 1/20 0.43
HTR1A P08908 3/20 0.41
HTR2A P28223 3/20 0.41
DRD3 P35462 3/20 0.41
LCAT P04180 1/20 0.41
SLC18A3 Q16572 1/20 0.40
PARP1 P09874 1/20 0.38
KCNH2 Q12809 1/20 0.38
CHRNA7 P36544 1/20 0.37
HRH4 Q9H3N8 2/20 0.37
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
GAA P10253 1/20 0.36
KMT2A Q03164 1/20 0.36
HCRTR1 O43613 1/20 0.36
HCRTR2 O43614 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL6072193 1.00 HTR3E (0.43) HTR3EHTR3BHTR3AHTR3DHTR3C
Trifluoroacetic Acid SCHEMBL6071803 0.83 KDM4E (0.45) SLC18A3KDM4EALDH1A1GAA
Trifluoroacetic Acid SCHEMBL6071354 0.80 SLC18A3 (0.48) SLC18A3KCNH2ALDH1A1GAAKMT2A
Trifluoroacetic Acid SCHEMBL6072071 0.79 SLC18A3 (0.62) SLC18A3CHRNA7
Trifluoroacetic Acid SCHEMBL4511663 0.79 HRH4 (0.54) HTR3EHTR3BHTR3AHTR3DHTR3C
Trifluoroacetic Acid SCHEMBL6071817 0.78 FAAH (0.43) SLC18A3KCNH2KDM4E
Trifluoroacetic Acid SCHEMBL6071718 0.77 MAPT (0.52) KDM4EALDH1A1KMT2A
Trifluoroacetic Acid SCHEMBL6072038 0.76 SLC18A3 (0.49) HTR3EHTR3BHTR3AHTR3DHTR3C
Trifluoroacetic Acid SCHEMBL6071855 0.76 SLC18A3 (0.45) HTR1ADRD3SLC18A3KCNH2KDM4E
Trifluoroacetic Acid SCHEMBL6071612 0.76 SLC18A3 (0.54) SLC18A3CHRNA7ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8399455-B2 Compounds useful as chemokine receptor antagonists MILLENNIUM PHARMACEUTICALS, INC. (US) 2013-03-19 US disclosed
US-20100234356-A1 COMPOUNDS USEFUL AS CHEMOKINE RECEPTOR ANTAGONISTS MILLENNIUM PHARMACEUTICALS, INC. (US) 2010-09-16 US disclosed
US-7635698-B2 Compounds useful as chemokine receptor antagonists MILLENNIUM PHARMACEUTICALS, INC. (US) 2009-12-22 US disclosed
US-20060189628-A1 Compounds useful as chemokine receptor antagonists MILLENNIUM PHARMACEUTICALS, INC. 2006-08-24 US disclosed
WO-2006071958-A1 COMPOUNDS USEFUL AS CHEMOKINE RECEPTOR ANTAGONISTS MILLENNIUM PHARMACEUTICALS, INC. (US) 2006-07-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100234356-A1 COMPOUNDS USEFUL AS CHEMOKINE RECEPTOR ANTAGONISTS ACKR3, CCR5, CXCR2 HTR3E 1875/4885HTR3B 1343/4885HTR3A 1848/4885
US-20060189628-A1 Compounds useful as chemokine receptor antagonists ACKR3, CCR5, CXCR2 HTR3E 1875/4885HTR3B 1343/4885HTR3A 1848/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.